Keytruda Expands Cervical Cancer Position With ESMO Data

 
• By Alaric DeArment
  
3d illustration of T cells attacking a cancer cell
Merck presented data at ESMO on Keytruda in first-line cervical cancer • Source: Shutterstock

More from Immuno-oncology

More from Anticancer